Co-Authors
This is a "connection" page, showing publications co-authored by Qihui Wang and Jianxun Qi.
Connection Strength
2.848
-
Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2. Cell. 2020 05 14; 181(4):894-904.e9.
Score: 0.876
-
Binding and molecular basis of the bat coronavirus RaTG13 virus to ACE2 in humans and other species. Cell. 2021 06 24; 184(13):3438-3451.e10.
Score: 0.237
-
Structural basis of HCoV-19 fusion core and an effective inhibition peptide against virus entry. Emerg Microbes Infect. 2020 Dec; 9(1):1238-1241.
Score: 0.229
-
Broad host range of SARS-CoV-2 and the molecular basis for SARS-CoV-2 binding to cat ACE2. Cell Discov. 2020; 6:68.
Score: 0.226
-
Structures of the four Ig-like domain LILRB2 and the four-domain LILRB1 and HLA-G1 complex. Cell Mol Immunol. 2020 09; 17(9):966-975.
Score: 0.208
-
Neutralization mechanism of human monoclonal antibodies against Rift Valley fever virus. Nat Microbiol. 2019 07; 4(7):1231-1241.
Score: 0.204
-
Bat origins of MERS-CoV supported by bat coronavirus HKU4 usage of human receptor CD26. Cell Host Microbe. 2014 Sep 10; 16(3):328-37.
Score: 0.149
-
The molecular basis for SARS-CoV-2 binding to dog ACE2. Nat Commun. 2021 07 07; 12(1):4195.
Score: 0.060
-
Molecular basis of cross-species ACE2 interactions with SARS-CoV-2-like viruses of pangolin origin. EMBO J. 2021 08 16; 40(16):e107786.
Score: 0.059
-
Cross-species recognition of SARS-CoV-2 to bat ACE2. Proc Natl Acad Sci U S A. 2021 01 05; 118(1).
Score: 0.058
-
A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2. Nature. 2020 08; 584(7819):120-124.
Score: 0.055
-
A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2. Science. 2020 06 12; 368(6496):1274-1278.
Score: 0.055
-
Molecular Basis of Binding between Middle East Respiratory Syndrome Coronavirus and CD26 from Seven Bat Species. J Virol. 2020 02 14; 94(5).
Score: 0.054
-
Limited Cross-Linking of 4-1BB by 4-1BB Ligand and the Agonist Monoclonal Antibody Utomilumab. Cell Rep. 2018 10 23; 25(4):909-920.e4.
Score: 0.049
-
Structure of the S1 subunit C-terminal domain from bat-derived coronavirus HKU5 spike protein. Virology. 2017 07; 507:101-109.
Score: 0.045
-
Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains. Nat Commun. 2017 04 10; 8:15092.
Score: 0.044
-
An unexpected N-terminal loop in PD-1 dominates binding by nivolumab. Nat Commun. 2017 02 06; 8:14369.
Score: 0.044
-
Protective T Cell Responses Featured by Concordant Recognition of Middle East Respiratory Syndrome Coronavirus-Derived CD8+ T Cell Epitopes and Host MHC. J Immunol. 2017 01 15; 198(2):873-882.
Score: 0.043
-
Putative Receptor Binding Domain of Bat-Derived Coronavirus HKU9 Spike Protein: Evolution of Betacoronavirus Receptor Binding Motifs. Biochemistry. 2016 Nov 01; 55(43):5977-5988.
Score: 0.043
-
A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein. Cell Res. 2015 Nov; 25(11):1237-49.
Score: 0.040
-
Structure of the fusion core and inhibition of fusion by a heptad repeat peptide derived from the S protein of Middle East respiratory syndrome coronavirus. J Virol. 2013 Dec; 87(24):13134-40.
Score: 0.035
-
Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26. Nature. 2013 Aug 08; 500(7461):227-31.
Score: 0.034